Literature DB >> 22006150

Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.

Derek H Chu, Abby S Van Voorhees, Misha Rosenbach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006150     DOI: 10.1001/archdermatol.2011.275

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  7 in total

1.  Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial.

Authors:  Tadashi Terui; Satomi Kobayashi; Yukari Okubo; Masamoto Murakami; Keiichiro Hirose; Hiroshi Kubo
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

2.  TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management.

Authors:  Sara Jiayang Li; Lourdes M Perez-Chada; Joseph F Merola
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2018-11-21

Review 3.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228

Review 4.  Next generation of biologics for the treatment of Crohn's disease: an evidence-based review on ustekinumab.

Authors:  Aranzazu Jauregui-Amezaga; Michael Somers; Heiko De Schepper; Elisabeth Macken
Journal:  Clin Exp Gastroenterol       Date:  2017-11-15

5.  Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of case.

Authors:  Yixin Ally Wang; Misha Rosenbach
Journal:  JAAD Case Rep       Date:  2020-01-22

Review 6.  Evidence-based efficacy of methotrexate in adult Crohn's disease in different intestinal and extraintestinal indications.

Authors:  Andrea Cassinotti; Alberto Batticciotto; Marco Parravicini; Maurizio Lombardo; Paolo Radice; Claudio Camillo Cortelezzi; Simone Segato; Federico Zanzi; Antonella Cappelli; Sergio Segato
Journal:  Therap Adv Gastroenterol       Date:  2022-03-23       Impact factor: 4.409

7.  Emerging dermatological and systemic applications of ustekinumab: beyond its clinical use in psoriasis.

Authors:  Shailendra Kapoor
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.